A Giachetti|P A Shore - JoVE Visualize

Showing results (131-140 of 147) with videos related to

Pageof 15

Sort By:

Neuropeptides|November 1, 1992

Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth musclesC A Maggi, S Giuliani, R Patacchini, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987

(R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptorsS H Zorn, R S Duman, A Giachetti, et al.

Journal of Neural Transmission|January 1, 1979

Dopaminergic neuronal responses to a non-amphetamine CNS stimulantD C German, H Harden, M K Sanghera, et al.

Oncogene|November 15, 2011

EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicityS Donnini, F Finetti, E Terzuoli, et al.

Journal of Medicinal Chemistry|October 14, 1994

Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonistsL Quartara, G Fabbri, R Ricci, et al.

British Journal of Pharmacology|March 1, 1995

Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistR Cirillo, A R Renzetti, P Cucchi, et al.

Journal of Medicinal Chemistry|March 1, 1984

(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonistsA Donetti, E Cereda, E Bellora, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991

In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376C A Maggi, S Giuliani, L Ballati, et al.

European Journal of Pharmacology|August 28, 1990

Direct evidence for the involvement of vasoactive intestinal polypeptide in the motor response of the human isolated ileum to capsaicinC A Maggi, S Giuliani, P Santicioli, et al.

Brain Research Bulletin|May 1, 1984

Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neuronsR T Matthews, B A McMillen, S G Speciale, et al.

Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:

Pageof 15

Neuropeptides|November 1, 1992

Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth musclesC A Maggi, S Giuliani, R Patacchini, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987

(R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptorsS H Zorn, R S Duman, A Giachetti, et al.

Journal of Neural Transmission|January 1, 1979

Dopaminergic neuronal responses to a non-amphetamine CNS stimulantD C German, H Harden, M K Sanghera, et al.

Oncogene|November 15, 2011

EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicityS Donnini, F Finetti, E Terzuoli, et al.

Journal of Medicinal Chemistry|October 14, 1994

Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonistsL Quartara, G Fabbri, R Ricci, et al.

British Journal of Pharmacology|March 1, 1995

Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistR Cirillo, A R Renzetti, P Cucchi, et al.

Journal of Medicinal Chemistry|March 1, 1984

(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonistsA Donetti, E Cereda, E Bellora, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991

In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376C A Maggi, S Giuliani, L Ballati, et al.

European Journal of Pharmacology|August 28, 1990

Direct evidence for the involvement of vasoactive intestinal polypeptide in the motor response of the human isolated ileum to capsaicinC A Maggi, S Giuliani, P Santicioli, et al.

Brain Research Bulletin|May 1, 1984

Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neuronsR T Matthews, B A McMillen, S G Speciale, et al.

Pageof 15